Jounce Therapeutics Inc.

NASDAQ: JNCE · Real-Time Price · USD
1.88
0.00 (0.00%)
At close: May 03, 2023, 10:00 PM

Jounce Therapeutics Revenue

Jounce Therapeutics reported an annual revenue of $82M, reflecting a 204.75% growth. For the quarter ending December 31, 2022, Jounce Therapeutics generated $82M in revenue.
Revenue (ttm)
82M
Revenue Growth
204.75%
Price / Sales Ratio
0.7
Revenue / Employee
581.56K
Employees
141
Market Cap
98.95M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.